> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Withdraws Approval for 4 B. Braun Medical Drugs
- URL: https://www.fdaweb.com/fda-withdraws-approval-for-4-b-braun-medical-drugs/
- Published: 2017-08-03T12:00:00.000Z
- Updated: 2026-09-14T22:38:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139296

*Federal Register* notice: FDA has announced that it is withdrawing approval of three NDAs and one ANDA held by B. Braun Medical. The company notified the agency that the products are no longer marketed and requested that the approval of the applications be withdrawn. Affected products include Dextran 70 (6% Dextran 70 in 0.9% NaCl injection); Dextran 40 (10% Dextran 40 in 0.9% NaCl injection and 10% Dextran 40 in 5% Dextrose); . Pentaspan (10% pentastarch in 0.9% NaCl injection in EXCEL containers); and Hespan (6% hetastarch in 0.9% NaCl in EXCEL containers).